Evidence map›Paper›PMID 42047332›Full record

ReviewAutophagy2026

Exploiting autophagy-targeting natural compounds for potential antimicrobial actions.

Seungwha Paik, Soohyun Um, In Soo Kim, Eun-Jin Park, Kyung Tae Kim, Joyoti Basu, Dong-Chan Oh, Eun-Kyeong Jo

Abstract readReview
In one paragraph

Review in Autophagy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Seungwha PaikDepartment of Microbiology, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.ORCID 0000-0002-5015-1494
Soohyun UmDepartment of Forest Products and Biotechnology, Kookmin University, Seoul, Republic of Korea.
In Soo KimDepartment of Medical Science, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.ORCID 0000-0002-9201-1086
Eun-Jin ParkDepartment of Microbiology, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.ORCID 0000-0002-1014-4820
Kyung Tae KimDepartment of Microbiology, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.ORCID 0000-0002-7843-2554
Joyoti BasuDepartment of Chemical Sciences, Bose Institute, Kolkata, India.ORCID 0000-0002-0497-9581
Dong-Chan OhNatural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.ORCID 0000-0001-6405-5535
Eun-Kyeong JoDepartment of Microbiology, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.ORCID 0000-0001-7191-0587

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural products are biologically active compounds used for therapeutic interventions for various diseases, particularly infections. Autophagy is an intracellular catabolic pathway involving lysosomal degradation and is closely associated with immunological pathways, effectively combating bacterial, viral, fungal, and parasitic infections. Accumulating evidence suggests that autophagy activation or inhibition by natural products promotes antimicrobial responses against various pathogens. Numerous natural products can modulate autophagy through diverse signaling pathways, suggesting their potential as a host-directed therapeutic strategy that may complement conventional drug regimens or help mitigate drug resistance in various infectious diseases. However, it remains largely unclear whether these effects are mediated by direct modulation of autophagy or indirectly through associated mechanisms, including enhanced immune defense, attenuation of pathological inflammation, or crosstalk with other organelle functions. Additionally, multiple pathogens can evade host responses; thus, autophagy activation may inadvertently create favorable conditions for certain pathogens. This review discusses the current knowledge of natural products in terms of their antimicrobial actions through autophagy regulation, particularly the roles of distinct natural product classes, such as polyphenols, alkaloids, terpenoids, quinones, peptides, and macrolides in modulating autophagy for potentially contributing to control various infectious diseases. Exploring the intricate molecular interplay between natural products and autophagy in limiting infections may provide valuable insights that could inform the development of innovative host-directed antimicrobial treatments based on autophagy regulation.

Indexed as

Anti-Infective AgentsAutophagyBiological ProductsAnimalsHost-Directed TherapyHumansSignal TransductionAnti-Infective AgentsBiological ProductsAlkaloidsautophagyhost-directed therapyinfectionnatural productpolyphenolsterpenoids

Identifiers

PMID42047332
PMCPMC13557593

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.